KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Finished Goods (2016 - 2025)

Zimmer Biomet Holdings has reported Finished Goods over the past 15 years, most recently at $1.8 billion for Q4 2025.

  • Quarterly results put Finished Goods at $1.8 billion for Q4 2025, up 3.41% from a year ago — trailing twelve months through Dec 2025 was $1.8 billion (up 3.41% YoY), and the annual figure for FY2025 was $1.8 billion, up 3.41%.
  • Finished Goods for Q4 2025 was $1.8 billion at Zimmer Biomet Holdings, down from $2.0 billion in the prior quarter.
  • Over the last five years, Finished Goods for ZBH hit a ceiling of $2.0 billion in Q2 2021 and a floor of $1.7 billion in Q4 2022.
  • Median Finished Goods over the past 5 years was $1.8 billion (2023), compared with a mean of $1.8 billion.
  • Biggest five-year swings in Finished Goods: decreased 16.82% in 2022 and later increased 10.65% in 2023.
  • Zimmer Biomet Holdings' Finished Goods stood at $1.7 billion in 2021, then dropped by 4.29% to $1.7 billion in 2022, then grew by 10.65% to $1.8 billion in 2023, then decreased by 3.25% to $1.8 billion in 2024, then grew by 3.41% to $1.8 billion in 2025.
  • The last three reported values for Finished Goods were $1.8 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.0 billion (Q2 2025) per Business Quant data.